UK markets closed

HCi VioCare (VICA)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00010.0000 (0.00%)
At close: 11:06AM EDT

HCi VioCare

Kintyre House
209 Govan Road
Glasgow G51 1HJ
United Kingdom
44 1413 700 321
https://rafina-innovations.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees4

Key executives

NameTitlePayExercisedYear born
Mr. Nikolaos KardarasHead of Legal DepartmentN/AN/A1950
Ms. Paraskevi PilarinouFinancial Controller115.82kN/AN/A
Ms. Paraskevi PylarinouCFO, Secretary & DirectorN/AN/A1988
Dr. Hari ElangovanActing Chief Technology OfficerN/AN/AN/A
Ms. Evaggelia MoschidouMarketing DirectorN/AN/AN/A
Mr. Georgios ThrapsaniotisTreasurer & DirectorN/AN/A1945
Mr. Yiannis LevantisIndependent Technology Advisor & DirectorN/AN/A1976
Amounts are as of 31 December 2018, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Rafina Innovations Inc. engages in the research, development, commercialization, and marketing of medical technologies. It operates through two segments, Clinics and Technology. The company also operates prosthetics and orthotics, and diabetic foot total rehabilitation clinics in Southern Europe, the Middle East, and North Africa. In addition, it is involved in the research, development, and commercialization of medical devices, methods, and products in the fields of prosthetics, orthotics, rehabilitation, bioengineering, mobility, diabetes, diabetic foot, tissue mechanics, ultrasonics, medical signal processing and analysis, medical technology, orthopedics, and robotic surgery; and licensing of its proprietary technologies. The company was formerly known as HCi Viocare and changed its name to Rafina Innovations Inc. in July 2018. Rafina Innovations Inc. was founded in 2007 and is based in Glasgow, the United Kingdom.

Corporate governance

HCi VioCare’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.